팝업레이어 알림
팝업레이어 알림이 없습니다.
본문 바로가기
주메뉴 바로가기
푸터 바로가기
검색창
검색
Login
Sign Up
주메뉴
HOME
Dok-Tok
History
Liked
LIVE
닫기
모바일 메뉴
Login
Sign Up
주요메뉴
All
Fexuclue 101
5-minute FexuQnA
Lecture Videos
Conferences
Fexuclue Case Study
이전
다음
The Latest Videos
이전
다음
FexuQnA: How are Fexuclue and K-CAB different?
Watch Now
FexuQnA: How Does LPRD Compare to GERD in Terms of Recurrence, and How to Prevent them?
Watch Now
Latest Knowledge on GERD Treatment & Guidelines | Dr. Soo-Hyun Lee
Watch Now
FEXUFORUM 2024 Live Replay
이전
다음
좋아요
Fexuforum 2024: Q&A Session (11 Questions)
2024.11.22
좋아요
Fexuforum 2024: Treatment of H. pylori in Special Populations with Penicillin and Other Drug Allergies
2024.11.21
좋아요
Fexuforum 2024: Efficacy of Fexuprazan in Treating Erosive Esophagitis and NERD | Symptomatic and Mucosal Healing Outcomes
2024.11.21
좋아요
Fexuforum 2024: New Therapeutic Options with Fexuprazan
2024.11.21
좋아요
Fexuforum 2024: Managing Difficulties to Treat GERD
2024.11.21
Fexuclue A-Z: Dr's Most Frequently Asked Questions
이전
다음
좋아요
Fexuclue A-Z: What Doctors Think About the Recent Changes in GERD Treatment
2024.11.22
좋아요
Fexuclue A-Z: The Most Beneficial Aspects of Fexuclue Based on Real-Life Cases
2024.11.22
좋아요
Fexuclue A-Z: What Should Be Fexuclue’s Future Direction in GERD Treatment?
2024.11.22
좋아요
Fexuclue A-Z: How Effective Is Fexuclue in Treating Conditions Other Than GERD, Like Functional Dyspepsia and Gastroparesis?
2024.11.22
좋아요
Fexuclue A-Z: Are There Any Side Effects of Long-Term Use of P-CABs?
2024.11.22
Fexuclue 101: The Basics
이전
다음
좋아요
FEXUCLUE: The New Wave of GERD Treatment (Clinical Standing and Global Status of Fexuclue)
2024.09.09
좋아요
FEXUCLUE 101: Development History of Fexuprazan
2024.09.04
좋아요
FEXUCLUE 101: 6 Value Propositions of Fexuprazan
2024.09.04
좋아요
FEXUCLUE 101: How 5 Benefits of P-CAB Overcomes the Unmet Needs of PPI
2024.09.04
좋아요
FEXUCLUE 101: 5 Unmet Needs of PPI & Its Mechanism
2024.09.04
Conference
이전
다음
좋아요
Tirzepatide for MASH with Liver Fibrosis
2024.11.01
좋아요
Survodutide for People with MASH and Fibrosis
2024.11.01
좋아요
Post Colonoscopy Colorectal Cancer - From Assessing to Avoiding
2024.11.01
좋아요
ASGE: Management of Complex or Malignant Polyp (Case 2-3)
2024.04.15
좋아요
ASGE: Management of Complex or Malignant Polyp (Case 1)
2024.04.11
Fexuclue Case Studies (In Korea)
이전
다음
좋아요
Cases of Fexuclue's Effect #6: Globus Treatment & QnA
2024.06.13
좋아요
Cases of Fexuclue's Effects #5: Increased Meal Compliance
2024.06.13
좋아요
Cases of Fexuclue's Effect #4: Chronic Cough Improvement
2024.06.13
좋아요
Cases of Fexuclue's Effect #3: Night-time Acid Breakthrough (NAB) Control
2024.04.14
좋아요
Cases of Fexuclue's Effect #2: Superior Heartburn Relief
2024.04.14
좋아요
Cases of Fexuclue's Effect #1: Full & Fast Onset
2024.04.11
Fexuclue in Korean Internal Medicine Clinics
이전
다음
좋아요
FexuQnA: How would you prescribe for patients also on DAPTs? Is DAPT+PPI recommendable?
2024.09.09
좋아요
FexuQnA: Is it necessary to follow the 4 week recommended prescription for Fexuclue?
2024.09.09
좋아요
FexuQnA: How to treat GERD patients non-responsive to PPI? Would Fexuclue be effective?
2024.09.09
좋아요
FexuQnA: Among many acid suppressants (H2RA, PPI, P-CAB..), how do we decide which medication to use for which patient?
2024.09.09
좋아요
Latest Knowledge on GERD Treatment and Introduction to Fexuclue | Dr. Se-Jin Hwang
2024.04.11
PPI vs. P-CAB as Discussed by GI & ENT Doctors
이전
다음
좋아요
FexuQnA: How would you treat patients presenting with GERD and Functional Dyspepsia symptoms?
2024.09.09
좋아요
FexuQnA: Can I use Fexuclue instead of PPI to prevent ulcers or bleeding?
2024.09.09
좋아요
FexuQnA: For Initial GERD Patients, Should I Choose PPI or P-CAB, and Why?
2024.09.06
좋아요
FexuQnA: What Is the Most Effective Treatment for Persistent Foreign Body Sensation (Globus)?
2024.09.06
좋아요
Introduction to the New Wave of GERD Treatment, Fexuclue | Dr. Shin-Hyung Jo
2024.05.30
좋아요
Strategies of LPRD Treatment with Fexuclue | Dr. Nam-Kook Kim
2024.05.30